Monday, 13th October
The 16th Australian Peptide Conference 2025
Days
Sunday, 12th October
Monday, 13th October
Tuesday, 14th October
Wednesday, 15th October
Thursday, 16th October
Search
Speakers
Session 2: Synthetic Technologies I
8:30AM - 10:30AM
Monday, 13th October
Chancellor 2
Chairs: Christoph Nitsche & Ratmir Derda
Chemical Tools for Biological Discoveries
-
Monika Raj
Radical Mediated Installation of
18
F tags into Proteins for Dynamic PET Imaging of Neurodegeneration Biomarkers
-
Andew M Giltrap
Late stage, traceless C–H functionalisation of peptides
-
Craig Hutton
Engineering approaches for improving the efficacy of peptide-based drug leads
-
Nicole Lawrence
Advancing ADC Technology: A Solid-Phase Platform for Cleavable Linker-Payload Synthesis
-
Iman Kavianinia
From Overlooked to Essential: CADIs in Peptidomimetic Design
-
Tetsuo Narumi
Morning Tea
10:30AM - 11:00AM
Monday, 13th October
Convention Centre Foyer
Session 3: Venoms
11:00AM - 1:00PM
Monday, 13th October
Chancellor 2
Chairs: Andrew Walker & Samuel Robinson
Uncovering Additional Complexity of Snake Venoms through Structural Proteomics
-
Tara L Pukala
Discovery of Stinging Nettle Neurotoxins
-
Thomas Durek
Arachnid Venom Peptides as Bioinsecticide Candidates for Varroa Mite and Locust Control
-
Shaodong Guo
Molecular mimicry by venom peptides
-
Samuel Robinson
A New Mode of Ion Channel Modulation: Dual Pharmacophore Binding of the Gympietides to TMEM233 and NaV1.7
-
Irina Vetter
Unveiling the Vampire Bat’s Secret: Ex Vivo Insights into CGRP-Mediated Vasodilation
-
Jan Tytgat
Lunch
1:00PM - 2:00PM
Monday, 13th October
Convention Centre Foyer
Session 4: Biosynthesis and Novel Bioactives I
2:00PM - 3:30PM
Monday, 13th October
Chancellor 2
Chair: Max Cryle
Utilizing Bioinformatics, Biocatalysis, and Synthetic Chemistry to Access Natural Product-Inspired Peptides
-
Elizabeth (Betsy) I Parkinson
⍺-contoxin binding at nicotinic acetylcholine receptors reveals general features of peptide antagonism
-
Jesko Koehnke
Developing antimicrobial peptides to combat infections
-
Wenyi Li
Peptidyl epoxyketone proteasome inhibitor biosynthesis: Substrate scope and catalytic mechanism of epoxyketone synthase EpnF
-
Gregory L Challis
Afternoon Tea
3:30PM - 4:00PM
Monday, 13th October
Convention Centre Foyer
Session 5: Towards the Clinic I
4:00PM - 6:00PM
Monday, 13th October
Chancellor 2
Chairs: Markus Muttenthaler & Aimee Horsfall
Sponsored by:
Rational Design of Functional Knottin Libraries through Computational Sequence Generation
-
Paula Florez
Potential therapeutic indications of orexin receptor modulators
-
Laura Jacobson
Breaking antibacterial resistance: Octapeptin lipopeptides potentiate repurposed drugs against multidrug-resistant bacteria
-
Mark AT Blaskovich
Targeting hGIIA-EGFR-vimentin interactions with cyclic peptide kesonotide: a novel strategy against Prostate cancer
-
Quach Truong
Oral Hepcidin Peptidomimetics to treat iron dysregulation
-
Greg T Bourne
Casual Dinner
6:00PM - 7:30PM
Monday, 13th October
Chancellor 1
Sponsored by:
Poster Session 1 & Wine Tasting
7:30PM - 10:00PM
Monday, 13th October
Convention Centre Foyer
Sponsored by:
Macrocyclic Sulfopeptide-Based LYTACs for Targeted Degradation of Chemokines
-
Bernardo Cavallazzi Sebold
Venom-derived blood-brain barrier peptide shuttles
-
Leonardo Marcazzan
Bio-aerogels fabricated from Tachykinin derived Ultrashort Peptides
-
Brody McDonald
Structure-based design,
in vitro
evaluation and
in vivo
imaging of a novel peptidomimetic inhibiting the uPA-uPAR interaction
-
Esaü Vangeloven
Prediction and identification of physicochemical determinates specific of antimicrobial and cell penetrating peptides
-
Ashok kumar
Ultrasound-assisted enzymatic hydrolysis enhances bioactive peptide yield and bioactivity from common bean and pumpkin seed proteins: antioxidant, anti-inflammatory and anti-steatotic effects
-
Erick Huerta-Rodriguez
Dissecting the trefoil domain folding process through directed disulfide bond formation
-
John Raju
The total chemical synthesis of HCRG21, a venom-derived inhibitor of TRPV1 with therapeutic Potential
-
Jinwei Sun
Development of pan-JAK inhibitor for alopecia areata (AA)
-
Hey Pui Carina Cheung
Cysteine-Ferroptosis Axis in Osteoarthritis: From Proteomics to Peptide Therapeutic Design
-
Luxi Zheng
Targeting Sclerostin Loop 3 with a Peptide Inhibitor
-
Gongli Cai
Synthesis of Chloroalkene-Based Peptidomimetics and Their Application as Amyloid-beta Aggregation Inhibitors
-
Kenichi Yamamoto
Discovery of highly stable nature-derived disulfide-rich peptide scaffolds
-
Rizana Azees
Phage-encoded bismuth bicycles enable instant access to targeted bioactive peptides
-
Upamali Somathilake
Assembling branched and macrocyclic peptides on proteins
-
Santhanalaxmi Kumaresan
Chemo-Enzymatic Peptide Synthesis
-
Christopher McGee
Developing a High-Throughput Screen for Conotoxin Agonists of the GABA
B
Receptor
-
Liam Jackson
The innate immune mediator group IIA secreted phospholipase A2 and its inhibition by KM3 modulates lipid droplet formation in prostate cancer cells.
-
Monavvar Andarva
Design and development of potent and selective C5aR2 agonists
-
Joshua Dent
Non-Symmetric Cysteine Stapling in Native Peptides and Proteins
-
Bishvanwesha Panda
Identifying the Binding Site of an Australian Stinging Nettle Toxin on a Novel Voltage-Gated Sodium Channel Accessory Protein
-
Lucinda Walker
Next-Generation Molecular Tools for Probing the Oxytocin Receptor
-
Monika Perisic Böhm
Phage-derived peptides that bind NONO to target telomerase-positive cancers
-
Tianyi Gao
Toward precision diagnostics in RA: exploiting the SFTI-1 scaffold for autoantibody profiling
-
Mingshu Zhang
Development of chemoenzymatic methods for the synthesis of peptide epoxyketones
-
Urvi Modak
The power of peptides for efficient crop protection
-
Annalise Taylor
Origin and diversification of melittin-family toxins in bees
-
William Atherton
Towards the Generation of Glutathione-Sensitive Linkers for Multi-Drug Antibody Drug Conjugates
-
Suzie M Chan
Unlocking the Potential of Hydrazide-Based Native Chemical Ligation with a Novel Dual-Linker Solubilising Platform
-
Keziah Poggenpoel
A Cancer Prodrug Activated by an Oncolytic Virus
-
Polly Chuanrong Sun
Understanding the mechanism of Proline-rich antimicrobial peptides
-
Yujie Zhu
Developing a novel brain-penetrating drug for appetite regulation
-
Isabelle Riches
Membrane-Targeting Magainin 2-Derived Peptides as Promising Candidates Against Carbapenem-Resistant
Enterobacteriaceae
Infections
-
Tianmeng Zhang
Peptidomimetics to inhibit the SLIT2-ROBO1 interaction as a gateway to attenuate pancreatic adenocarcinoma
-
Mohsen Hosseini
Natural Defense, Model Response: Cyclotides from Bolivian Plants in
C. elegans
-
Jose Antonio J Ruiz Machicao
Photoswitchable peptidic modulators of Acid-Sensing Ion Channels
-
Nataliia Petlovana
A High-Throughput Synthetic Evolution Platform for Developing Next-Generation Antimicrobials
-
Praveen Praveen
Dissecting the tripartite interaction of pain-causing stinging nettle peptides with TMEM233 and sodium channels
-
Qing Xu
← Sunday
Tuesday →